Danilo Perrotti

15.4k total citations · 1 hit paper
123 papers, 9.0k citations indexed

About

Danilo Perrotti is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Danilo Perrotti has authored 123 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Hematology, 67 papers in Molecular Biology and 33 papers in Genetics. Recurrent topics in Danilo Perrotti's work include Chronic Myeloid Leukemia Treatments (54 papers), Acute Myeloid Leukemia Research (43 papers) and Chronic Lymphocytic Leukemia Research (21 papers). Danilo Perrotti is often cited by papers focused on Chronic Myeloid Leukemia Treatments (54 papers), Acute Myeloid Leukemia Research (43 papers) and Chronic Lymphocytic Leukemia Research (21 papers). Danilo Perrotti collaborates with scholars based in United States, Italy and Canada. Danilo Perrotti's co-authors include Bruno Calabretta, Paolo Neviani, Michael A. Caligiuri, Guido Marcucci, Ramasamy Santhanam, Rossana Trotta, Tomasz Skórski, Carlo M. Croce, Clara D. Bloomfield and John M. Goldman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Danilo Perrotti

121 papers receiving 8.8k citations

Hit Papers

MicroRNAs bind to Toll-like receptors to induce prometast... 2012 2026 2016 2021 2012 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danilo Perrotti United States 50 5.9k 3.2k 2.1k 1.7k 1.3k 123 9.0k
Justus Duyster Germany 52 3.9k 0.7× 3.5k 1.1× 1.2k 0.6× 2.2k 1.3× 1.5k 1.2× 261 9.0k
John D. Crispino United States 52 5.0k 0.8× 3.2k 1.0× 678 0.3× 1.7k 1.0× 985 0.8× 168 8.1k
Christine Chomienne France 56 10.1k 1.7× 6.8k 2.1× 674 0.3× 2.0k 1.2× 1.4k 1.1× 248 12.8k
Joop H. Jansen Netherlands 41 4.4k 0.8× 2.9k 0.9× 649 0.3× 951 0.6× 1.4k 1.1× 155 7.0k
Steffen Koschmieder Germany 37 2.8k 0.5× 2.4k 0.7× 708 0.3× 1.7k 1.0× 708 0.6× 222 5.2k
William Matsui United States 54 6.1k 1.0× 2.5k 0.8× 1.7k 0.8× 1.1k 0.6× 1.7k 1.3× 154 10.8k
Itaru Matsumura Japan 39 2.5k 0.4× 2.0k 0.6× 503 0.2× 1.2k 0.7× 1.1k 0.9× 216 5.5k
Tessa L. Holyoake United Kingdom 59 3.8k 0.6× 7.5k 2.3× 846 0.4× 4.7k 2.8× 1.2k 1.0× 219 11.1k
Veronika Sexl Austria 51 3.3k 0.6× 1.5k 0.5× 1.1k 0.5× 1.1k 0.7× 4.4k 3.5× 183 9.5k
Hitoshi Kiyoi Japan 46 4.4k 0.7× 5.4k 1.7× 605 0.3× 2.0k 1.2× 1.2k 1.0× 277 9.0k

Countries citing papers authored by Danilo Perrotti

Since Specialization
Citations

This map shows the geographic impact of Danilo Perrotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danilo Perrotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danilo Perrotti more than expected).

Fields of papers citing papers by Danilo Perrotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danilo Perrotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danilo Perrotti. The network helps show where Danilo Perrotti may publish in the future.

Co-authorship network of co-authors of Danilo Perrotti

This figure shows the co-authorship network connecting the top 25 collaborators of Danilo Perrotti. A scholar is included among the top collaborators of Danilo Perrotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danilo Perrotti. Danilo Perrotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bailey, Christopher M., Rena G. Lapidus, Sandrine Niyongere, et al.. (2021). PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition–Dependent GSK-3β–Mediated c-Myc and Pim-1 Proteasomal Degradation. Molecular Cancer Therapeutics. 20(4). 676–690. 17 indexed citations
2.
Zhao, Dandan, Le Xuan Truong Nguyen, Fang Chen, et al.. (2021). Spred1 deficit promotes treatment resistance and transformation of chronic phase CML. Leukemia. 36(2). 492–506. 5 indexed citations
3.
Natarajan, Karthika, Rena G. Lapidus, Rossana Trotta, et al.. (2017). Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells through Increased Mcl-1 Proteasomal Degradation. Clinical Cancer Research. 24(1). 234–247. 36 indexed citations
4.
Perrotti, Danilo, et al.. (2016). Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay. Current Drug Targets. 18(4). 377–388. 19 indexed citations
5.
Muvarak, Nidal, Carine Robert, Maria R. Baer, et al.. (2015). c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias. Molecular Cancer Research. 13(4). 699–712. 54 indexed citations
6.
Li, Liang, YinWei Ho, Allen Lin, et al.. (2014). Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells. Blood. 123(18). 2826–2837. 84 indexed citations
7.
Huang, Xiaomeng, Sebastian Schwind, Bo Yu, et al.. (2013). Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia. Clinical Cancer Research. 19(9). 2355–2367. 151 indexed citations
8.
Fabbri, Muller, Alessio Paone, Federica Calore, et al.. (2012). MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proceedings of the National Academy of Sciences. 109(31). E2110–6. 1284 indexed citations breakdown →
9.
Roberts, Kathryn G., Amanda M. Smith, Fiona McDougall, et al.. (2010). Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers. Cancer Research. 70(13). 5438–5447. 100 indexed citations
10.
Perrotti, Danilo, Catriona Jamieson, John M. Goldman, & Tomasz Skórski. (2010). Chronic myeloid leukemia: mechanisms of blastic transformation. Journal of Clinical Investigation. 120(7). 2254–2264. 289 indexed citations
11.
Costinean, Stefan, Sukhinder K. Sandhu, Irene M. Pedersen, et al.. (2009). Src homology 2 domain–containing inositol-5-phosphatase and CCAAT enhancer-binding protein β are targeted by miR-155 in B cells of Eμ-MiR-155 transgenic mice. Blood. 114(7). 1374–1382. 235 indexed citations
12.
Benson, Don M., Jianhua Yu, Brian Becknell, et al.. (2008). Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells. Blood. 113(12). 2706–2714. 39 indexed citations
13.
Trotta, Rossana, Jessica Dal Col, Jianhua Yu, et al.. (2008). TGF-β Utilizes SMAD3 to Inhibit CD16-Mediated IFN-γ Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells. The Journal of Immunology. 181(6). 3784–3792. 207 indexed citations
14.
Neviani, Paolo, Ramasamy Santhanam, Joshua J. Oaks, et al.. (2007). FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia. Journal of Clinical Investigation. 117(9). 2408–2421. 269 indexed citations
15.
Perrotti, Danilo, Francesco Turturro, & Paolo Neviani. (2005). BCR/ABL, mRNA translation and apoptosis. Cell Death and Differentiation. 12(6). 534–540. 17 indexed citations
16.
Iervolino, Angela, Giorgia Santilli, Rossana Trotta, et al.. (2002). hnRNP A1 Nucleocytoplasmic Shuttling Activity Is Required for Normal Myelopoiesis and BCR/ABL Leukemogenesis. Molecular and Cellular Biology. 22(7). 2255–2266. 100 indexed citations
17.
Manzella, Livia, Rossana Gualdi, Danilo Perrotti, et al.. (2000). The Interferon Regulatory Factors 1 and 2 Bind to a Segment of the Human c-myb First Intron: Possible Role in the Regulation of c-myb Expression. Experimental Cell Research. 256(1). 248–256. 12 indexed citations
18.
Perrotti, Danilo. (1998). TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. The EMBO Journal. 17(15). 4442–4455. 113 indexed citations
19.
Cimino, Letizia, Danilo Perrotti, Rita Falcioni, Stephen J. Kennel, & Ada Sacchi. (1991). \4 integrin expression onin vitro andin vivo metastatic variants of lewis lung carcinoma. Cytotechnology. 5(S1). 45–48. 3 indexed citations
20.
Gentileschi, Maria Pia, et al.. (1990). Metastatic phenotype: Growth factor dependence and integrin expression. Cell Biology International Reports. 14. 91–91. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026